Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO

JAMA Ophthalmology Author Interviews
18/10/2018 16 min
Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO

Listen "Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab for CRVO"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Ian Leslie. Mcallister, FRANZCO, author of Two-Year Efficacy of Ranibizumab Plus Laser-Induced Chorioretinal Anastomosis vs Ranibizumab Monotherapy for Central Retinal Vein Occlusion: A Randomized Clinical Trial

More episodes of the podcast JAMA Ophthalmology Author Interviews

Diabetes in the Donor and Descemet Membrane Endothelial Keratoplasty Success at 1 Year 17/10/2025
Smooth Pursuit Velocity After a Season of Repetitive Head Impacts in American Football Players 18/09/2025
Mammalian Target Rapamycin Inhibition for Proliferative Vitreoretinopathy 07/08/2025
Steroids and Cross-Linking for Ulcer Treatment 24/07/2025
From the JAMA Network: GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 17/07/2025
Gender Differences in Case Volume Among Ophthalmology Resident Graduates, 2014-2023 01/05/2025
Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab 06/03/2025
Shedding LiGHT on Selective Laser Trabeculoplasty 20/02/2025
Ophthalmic Complications Associated With Semaglutide and Tirzepatide 30/01/2025
Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in ROP 26/12/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA